SMAD2 and cholangiocarcinoma: Here, we knocked down AL161431.1 using specific siRNAs, then, the western blot indicated that AL161431.1 could activate TGFβ pathway via the upregulation of phosphorylated SMAD2/SMAD3 to contribute to CCA metastasis.